Skip to main content
. 2016 Dec 7;22(45):10024–10037. doi: 10.3748/wjg.v22.i45.10024

Table 6.

Cox regression analysis of prognostic factors in pancreatic ductal adenocarcinoma patients with synchronous liver metastasis undergoing surgery

Parameter n Median OS (95%CI) (mo) Univariate analysis Multivariate analysis
P value Hazard ratio 95%CI P value
Age, yr
≤ 62 32 9.988 (5.215-14.760)
> 62 37 4.534 (3.294-5.774) 0.006 2.191 1.182-4.060 0.013
Sex
Male 47 5.388 (2.454-8.322)
Female 22 7.129 (5.820-8.439) 0.428
BMI, kg/m2
< 18 6 4.008 (0.000-8.701) 0.939
18-25 54 6.998 (5.147-8.849)
> 25 9 7.721 (1.548-13.894) 0.548
Smoke
No 50 7.031 (4.606-9.455)
Yes 19 5.979 (0.607-11.352) 0.317
ASA
I 21 9.988 (3.524-16.452)
II-III 48 6.998 (3.803-10.193) 0.273
Primary tumor location
Head/neck 53 6.998 (4.910-9.086)
Body/tail 16 7.129 (3.438-10.820) 0.762
CA19-9, U/mL
≤ 400 40 7.984 (6.454-9.513)
> 400 29 4.008 (2.832-5.185) 0.042 1.398 0.773-2.527 0.267
CA125, U/mL
≤ 62 32 9.035 (7.052-11.017)
> 62 37 4.008 (2.801-5.215) 0.003 2.601 1.403-4.823 0.002
CEA, U/mL
≤ 5 42 7.721 (6.340-9.102)
> 5 27 5.191 (1.847-8.535) 0.320
Fibrinogen, g/L
≤ 4.0 50 7.129 (5.373-8.886)
> 4.0 19 5.191 (2.575-7.807) 0.533
NLR
≤ 5 59 7.031 (5.123-8.939)
> 5 10 4.008 (0.000-9.812) 0.495
PLR
≤ 150 36 7.031 (4.545-9.517)
> 150 33 5.979 (3.287-8.672) 0.851
PNI
> 45 42 7.129 (6.237-8.022)
≤ 45 27 5.848 (3.396-8.300) 0.890
Platelet
≤ 250 × 109/L 53 6.998 (5.018-8.978)
> 250 × 109/L 16 7.097 (0.957-13.236) 0.993
Jaundice
No 34 7.721 (4.540-10.901)
Yes 35 6.998 (3.593-10.403) 0.446
Biliary drainage
No 45 7.129 (5.245-9.014)
Yes 24 5.027 (1.872-8.181) 0.878
Bilirubin, μmol/L
≤ 50 58 6.998 (4.918-9.078)
> 50 11 7.031 (1.408-12.651) 0.448
Albumin, g/L
> 35 42 7.097 (4.893-9.300)
≤ 35 27 5.027 (2.171-7.882) 0.799
Diabetes mellitus
No 39 6.998 (4.177-9.819)
Yes 30 6.998 (4.424-9.572) 0.300
Pancreatitis
No 42 5.979 (4.876-9.186)
Yes 27 6.998 (2.516-11.480) 0.789